Stock AXOVANT SCIENCES LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Axovant Sciences Ltd Nasdaq

Equities

BMG0750W1047

Business Summary

Sio Gene Therapies Inc. was a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. The Company has not generated any revenue.

Managers

Managers TitleAgeSince
David Nassif CEO
 Chief Executive Officer 70 19-06-30
Raquel Crystal COO
 Chief Operating Officer - -

Members of the board

Members of the board TitleAgeSince
David Nassif CEO
 Chief Executive Officer 70 19-06-30

Company contact information

Sio Gene Therapies, Inc.

1501 Broadway 12th floor

10036, New York

+877 746 4891

http://www.siogtx.com
address Axovant Sciences Ltd

Sector

This company's sector is not yet available
  1. Stock Market
  2. Equities
  3. SIOX Stock
  4. Stock
  5. Company Axovant Sciences Ltd